Quarterly report pursuant to Section 13 or 15(d)

Stock Options

v3.21.1
Stock Options
3 Months Ended
Mar. 31, 2021
Share-based Payment Arrangement [Abstract]  
Stock Options
14. STOCK OPTIONS

 

On December 20, 2019, the Company adopted its 2019 Omnibus Incentive Plan (the “Plan”).

 

At its discretion, the Company grants share option awards to certain employees and non-employees under the Plan and accounts for it in accordance with ASC 718, Compensation – Stock Compensation.

 

A summary of option activity for the three months ended March 31, 2021 is presented below.

 

                Weighted-        
          Weighted-     Average        
          Average     Remaining     Aggregate  
          Exercise     Contractual     Intrinsic  
    Options     Price     Life (Years)     Value  
                         
Outstanding at December 31, 2020     6,031,775     $ 1.55       2.68     $ 1,932,000  
Granted     664,000       1.38       -       -  
Forfeited     (564,032 )     1.87       -       -  
Exercised     (332,730 )     1.13       -       -  
Outstanding at March 31, 2021     5,799,013     $ 1.62       2.46     $ 387,000  
                                 
Vested March 31, 2021     3,304,078     $ 1.71             $ 322,000  
                                 
Exercisable at March 31, 2021     2,023,118     $ 1.94             $ 133,000  

  

At March 31, 2021, the intrinsic value of the outstanding options was $387,000.

 

During the quarter ended March 31, 2021, the Company granted stock options to employees to purchase a total of 664,000 shares of Common Stock for services rendered. The options have an average exercise price of $1.76 per share, expire in five years, vesting one and four years from grant date. The total fair value of these options at grant date was approximately $1,103,000 using the Black-Scholes Option Pricing model. The total stock compensation expense recognized relating to the vesting of stock options for the quarter ended March 31, 2021 amounted to $448,000. As of March 31, 2021, the total unrecognized stock-based compensation expense was $4,059,000, which is expected to be recognized as part of operating expense through March 2025. In addition, a total of 332,730 shares of stock options were exercised. As a result of the exercise of the option, the Company issued 332,730 shares of common stock and received cash of $377,000.

 

The fair value of share option award is estimated using the Black-Scholes option pricing method based on the following weighted-average assumptions:

 

    Three months ended March 31,  
    2021     2020  
Risk-free interest rate     0.10% - 0.36 %     0.39 %
Average expected term     5 years       5 years  
Expected volatility     240.03 %     270.1 %
Expected dividend yield     -       -  

 

The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of measurement corresponding with the expected term of the share option award; the expected term represents the weighted-average period of time that share option awards granted are expected to be outstanding giving consideration to vesting schedules and historical participant exercise behavior; the expected volatility is based upon historical volatility of the Company’s Common Stock; and the expected dividend yield is based on the fact that the Company has not paid dividends in the past and does not expect to pay dividends in the future.